Lichen planopilaris treated with a peroxisome proliferator-activated receptor γ agonist

Archives of Dermatology

Volumn 145, Issue 12, 2009, Pages 1363-1366

  Mirmirani, Paradi ^a,b,c   Karnik, Pratima ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DOXYCYCLINE HYCLATE; HYDROXYCHLOROQUINE SULFATE; KETOCONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PREDNISONE; TACROLIMUS;

ADULT; ALOPECIA; ARTICLE; CASE REPORT; HAIR FOLLICLE; HAIR LOSS; HUMAN; LICHEN; LICHEN PLANOPILARIS; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; SCALP; SCAR ALOPECIA; SKIN BIOPSY; TREATMENT DURATION;

ALOPECIA; HUMANS; HYPOGLYCEMIC AGENTS; LICHEN PLANUS; MALE; MIDDLE AGED; PPAR GAMMA; SCALP DERMATOSES; THIAZOLIDINEDIONES;

EID: 73149113545     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2009.283     Document Type: Article

References (18)

1. Mirmirani P, Willey A, Price VH. Short course of oral cyclosporine in lichen planopilaris. J Am Acad Dermatol. 2003;49(4):667-671.
2. Mirmirani P, Willey A, Headington JT, Stenn K, McCalmont TH, Price VH. Primary cicatricial alopecia: histopathologic findings do not distinguish clinical variants. J Am Acad Dermatol. 2005;52(4):637-643.
3. Price VH. The medical treatment of cicatricial alopecia. Semin Cutan Med Surg. 2006;25(1):56-59.
4. Harries MJ, Sinclair RD, Macdonald-Hull S, Whiting DA, Griffiths CE, Paus R. Management of primary cicatricial alopecias: options for treatment. Br J Dermatol. 2008;159(1):1-22.
5. Kang H, Alzolibani AA, Otberg N, Shapiro J. Lichen planopilaris. Dermatol Ther. 2008;21(4):249-256.
6. Karnik P, Tekeste Z, McCormick TS, et al. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. J Invest Dermatol. 2009;129(5): 1243-1257.
7. Ross EK, Tan E, Shapiro J. Update on primary cicatricial alopecias. J Am Acad Dermatol. 2005;53(1):1-37.
8. Olsen EA, Bergfeld WF, Cotsarelis G, et al; Workshop on Cicatricial Alopecia. Summary of North American Hair Research Society (NAHRS)-sponsored Workshop on Cicatricial Alopecia, Duke University Medical Center, February 10 and 11, 2001. J Am Acad Dermatol. 2003;48(1):103-110.
9. Wan Y, Saghatelian A, Chong LW, Zhang CL, Cravatt BF, Evans RM. Maternal PPAR gamma protects nursing neonates by suppressing the production of inflammatory milk. Genes Dev. 2007;21(15):1895-1908.
10. Jiang C, Ting AT, Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391(6662):82-86.
11. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferatoractivated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391(6662):79-82.
12. Sertznig P, Seifert M, Tilgen W, Reichrath J. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases. Am J Clin Dermatol. 2008;9(1):15-31.
13. Guan Y, Hao C, Cha DR, et al. Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med. 2005; 11(8):861-866.
14. Karalliedde J, Buckingham RE. Thiazolidinediones and their fluid-related adverse effects: facts, fiction and putative management strategies. Drug Saf. 2007; 30(9):741-753.
15. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med. 2007;356(24):2457-2471.
16. Scheen AJ. Pharmacokinetic interactions with thiazolidinediones. Clin Pharmacokinet. 2007;46(1):1-12.
17. Rivier MJA, Caron J, Busson M, Pillon A, Mallavialle A, Balaguer P. Identification of new PPAR gamma agonists optimized for topical administration using a bioluminescent animal model [Internat Invest Dermatol abstract 890]. J Invest Dermatol. 2008;128(suppl 1):S1-284.
18. Ochoa BE, King LE Jr, Price VH. Lichen planopilaris: annual incidence in four hair referral centers in the United States. J Am Acad Dermatol. 2008;58(2): 352-353.